Article Details
Retrieved on: 2022-02-04 01:11:44
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Kiromic BioPharma's < > former chair of the audit committee, Pietro Bersani was appointed as interim CEO to succeed Dr.
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here